Furfine ES - Search Results

1

Exploration of the P1 SAR of aldehyde cathepsin K inhibitors.

Catalano JG, Deaton DN, Furfine ES, Hassell AM, McFadyen RB, Miller AB, Miller LR, Shewchuk LM, Willard DH Jr, Wright LL. Catalano JG, et al. Among authors: furfine es. Bioorg Med Chem Lett. 2004 Jan 5;14(1):275-8. doi: 10.1016/j.bmcl.2003.09.088. Bioorg Med Chem Lett. 2004. PMID: 14684342

2

Novel spirocyclic pyrrolidones as P2/P1 mimetics in potent inhibitors of HIV-1 protease.

Kazmierski WM, Furfine E, Spaltenstein A, Wright LL. Kazmierski WM, et al. Bioorg Med Chem Lett. 2002 Dec 2;12(23):3431-3. doi: 10.1016/s0960-894x(02)00733-3. Bioorg Med Chem Lett. 2002. PMID: 12419377

3

Potent inhibitors of the HIV-1 protease incorporating cyclic urea P1-P2 scaffold.

Kazmierski WM, Furfine E, Gray-Nunez Y, Spaltenstein A, Wright L. Kazmierski WM, et al. Bioorg Med Chem Lett. 2004 Nov 15;14(22):5685-7. doi: 10.1016/j.bmcl.2004.08.038. Bioorg Med Chem Lett. 2004. PMID: 15482948

4

Discovery of potent pyrrolidone-based HIV-1 protease inhibitors with enhanced drug-like properties.

Kazmierski WM, Andrews W, Furfine E, Spaltenstein A, Wright L. Kazmierski WM, et al. Bioorg Med Chem Lett. 2004 Nov 15;14(22):5689-92. doi: 10.1016/j.bmcl.2004.08.039. Bioorg Med Chem Lett. 2004. PMID: 15482949

5

New, potent P1/P2-morpholinone-based HIV-protease inhibitors.

Kazmierski WM, Furfine E, Spaltenstein A, Wright LL. Kazmierski WM, et al. Bioorg Med Chem Lett. 2006 Oct 1;16(19):5226-30. doi: 10.1016/j.bmcl.2006.07.014. Epub 2006 Aug 10. Bioorg Med Chem Lett. 2006. PMID: 16904316

6

Optimization of pyrrolidinone based HIV protease inhibitors.

Sherrill RG, Andrews CW, Bock WJ, Davis-Ward RG, Furfine ES, Hazen RJ, Rutkowske RD, Spaltenstein A, Wright LL. Sherrill RG, et al. Among authors: furfine es. Bioorg Med Chem Lett. 2005 Jan 3;15(1):81-4. doi: 10.1016/j.bmcl.2004.10.029. Bioorg Med Chem Lett. 2005. PMID: 15582415

7

Synthesis and antiviral activities of novel N-alkoxy-arylsulfonamide-based HIV protease inhibitors.

Sherrill RG, Furfine ES, Hazen RJ, Miller JF, Reynolds DJ, Sammond DM, Spaltenstein A, Wheelan P, Wright LL. Sherrill RG, et al. Among authors: furfine es. Bioorg Med Chem Lett. 2005 Aug 1;15(15):3560-4. doi: 10.1016/j.bmcl.2005.05.101. Bioorg Med Chem Lett. 2005. PMID: 15975788

8

Novel inhibitors of HIV protease: design, synthesis and biological evaluation of picomolar inhibitors containing cyclic P1/P2 scaffolds.

Spaltenstein A, Almond MR, Bock WJ, Cleary DG, Furfine ES, Hazen RJ, Kazmierski WM, Salituro FG, Tung RD, Wright LL. Spaltenstein A, et al. Among authors: furfine es. Bioorg Med Chem Lett. 2000 Jun 5;10(11):1159-62. Bioorg Med Chem Lett. 2000. PMID: 10866371

9

Novel P1 chain-extended HIV protease inhibitors possessing potent anti-HIV activity and remarkable inverse antiviral resistance profiles.

Miller JF, Brieger M, Furfine ES, Hazen RJ, Kaldor I, Reynolds D, Sherrill RG, Spaltenstein A. Miller JF, et al. Among authors: furfine es. Bioorg Med Chem Lett. 2005 Aug 1;15(15):3496-500. doi: 10.1016/j.bmcl.2005.05.129. Bioorg Med Chem Lett. 2005. PMID: 15990305

10

Ultra-potent P1 modified arylsulfonamide HIV protease inhibitors: the discovery of GW0385.

Miller JF, Andrews CW, Brieger M, Furfine ES, Hale MR, Hanlon MH, Hazen RJ, Kaldor I, McLean EW, Reynolds D, Sammond DM, Spaltenstein A, Tung R, Turner EM, Xu RX, Sherrill RG. Miller JF, et al. Among authors: furfine es. Bioorg Med Chem Lett. 2006 Apr 1;16(7):1788-94. doi: 10.1016/j.bmcl.2006.01.035. Epub 2006 Feb 3. Bioorg Med Chem Lett. 2006. PMID: 16458505

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

52 results

Search Page

Filters